{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": 0.16401738, "regularMarketPrice": 9.16, "exchange": "FRA", "shortName": "BIOGAIA AB  B  O.N.", "longName": "BioGaia AB (publ)", "messageBoardId": "finmb_3733605", "exchangeTimezoneName": "Europe/Berlin", "market": "dr_market", "regularMarketTime": 1683871386, "regularMarketDayHigh": 9.16, "regularMarketDayRange": "9.16 - 9.16", "regularMarketDayLow": 9.16, "regularMarketVolume": 400, "regularMarketPreviousClose": 9.145, "bid": 9.035, "ask": 9.135, "fullExchangeName": "Frankfurt", "financialCurrency": "SEK", "regularMarketOpen": 9.16, "averageDailyVolume3Month": 33, "averageDailyVolume10Day": 40, "fiftyTwoWeekLowChange": 2.5149999, "fiftyTwoWeekLowChangePercent": 0.37848005, "fiftyTwoWeekRange": "6.645 - 10.74", "fiftyTwoWeekHighChange": -1.5799999, "fiftyTwoWeekHighChangePercent": -0.14711359, "fiftyTwoWeekLow": 6.645, "fiftyTwoWeekHigh": 10.74, "trailingAnnualDividendRate": 0.0, "trailingPE": 5.619632, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": 1.63, "sharesOutstanding": 97279000, "fiftyDayAverage": 8.4881, "fiftyDayAverageChange": 0.6718998, "fiftyDayAverageChangePercent": 0.07915785, "twoHundredDayAverage": 8.1309, "twoHundredDayAverageChange": 1.0290995, "twoHundredDayAverageChangePercent": 0.12656648, "marketCap": 974404160, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 952066800000, "priceHint": 2, "regularMarketChange": 0.01499939, "symbol": "BGLA.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Kungsbroplan 3", "city": "Stockholm", "zip": "112 27", "country": "Sweden", "phone": "46 8 55 52 93 00", "website": "https://www.biogaia.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "BioGaia AB (publ), a healthcare company, develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; Helicobacter pylori\u0096the gastric ulcer bacterium; low bone density; and diverticulitis, as well as baby and child gut, adult gut, immune, pregnancy, oral, and bone health. It offers its products under the BioGaia brand name. The company sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.", "fullTimeEmployees": 212, "companyOfficers": [{"maxAge": 1, "name": "Mr. Peter  Rothschild M.Sc. Econ., MBA", "age": 72, "title": "Founder & Chairman", "yearBorn": 1950, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Isabelle Valerie Ghislaine Ducellier", "age": 53, "title": "CEO & Pres", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Alexander  Kotsinas M.Sc. (Eng.).", "age": 55, "title": "Exec. VP & CFO", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ludvig  Milesson", "age": 45, "title": "Chief Operating Officer", "yearBorn": 1977, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Gianfranco  Grompone", "age": 47, "title": "Chief Scientific Officer and VP of R&D", "yearBorn": 1975, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Caroline  Mofors", "age": 50, "title": "Chief Legal Officer", "yearBorn": 1972, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Eva  Nelson", "title": "Corp. Communications Mang.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Linda  Hagglund", "age": 49, "title": "VP of Marketing", "yearBorn": 1973, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Angelika  Kjelldorff", "age": 53, "title": "Chief HR Officer", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Sebastian  Heimfors", "age": 48, "title": "VP & Chief Commercial Officer", "yearBorn": 1974, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 5, "shareHolderRightsRisk": 8, "overallRisk": 6, "governanceEpochDate": 1682899200, "maxAge": 86400}}], "error": null}}